EYLEA HD demonstrated non-inferior vision gains with an every 8-week dosing regimen compared to EYLEA® (aflibercept) Injection 2 mg dosed…
NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology…
Agreement Supports Phase IIb and Future Phase III Trial Development,Addressing Critical Needs in Palliative Care Using Optimi's Natural Psilocybin ExtractVancouver,…
Demand from new pharmaceutical and existing customers reaffirms the newly expanded D/Quarters' vital role in nurturing innovation at Dubai Science ParkDUBAI,…
HONG KONG, Dec. 17, 2024 /PRNewswire/ -- Great Bay Bio (GBB) is thrilled to announce the successful first close of its…
Key Trends, Metrics, and Best Practices Unveiled to Optimize Incentive Strategies and Drive Performance in Life Sciences BERKELEY HEIGHTS, N.J.,…
New datma Patent Simplifies the Integration of Pathology Data into datma.FED Platform BEAVERTON, Ore., Dec. 16, 2024 /PRNewswire/ -- datma, a…
The term sheet is non-binding, subject to the execution of a definitive agreement Vancouver, Canada, Dec. 16, 2024 (GLOBE NEWSWIRE)…
Toronto, Ontario--(Newsfile Corp. - December 16, 2024) - Neural Therapeutics Inc. ("Neural" or the "Company"), an ethnobotanical drug discovery company…
Company unveils breakthrough platform that integrates epiproteomics and AI to identify predictive biomarkers for personalized treatments and support drug development…